ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

AV. Aviva Plc

492.70
4.30 (0.88%)
26 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Aviva Plc LSE:AV. London Ordinary Share GB00BPQY8M80 ORD 32 17/19P
  Price Change % Change Share Price Shares Traded Last Trade
  4.30 0.88% 492.70 2,398,995 16:35:27
Bid Price Offer Price High Price Low Price Open Price
492.90 493.10 493.30 486.40 487.30
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Insurance Carriers, Nec 41.43B 1.09B 0.3961 12.45 13.38B
Last Trade Time Trade Type Trade Size Trade Price Currency
16:49:11 O 51 492.70 GBX

Aviva (AV.) Latest News

Aviva (AV.) Discussions and Chat

Aviva Forums and Chat

Date Time Title Posts
26/7/202420:56AVIVA PLC 19,684
22/7/202419:54Aviva25,503
16/3/202417:45AV. for alternative views11
13/3/202417:45No-Raj Union ?2
05/4/202318:44Aviva SLa Lgen??2

Add a New Thread

Aviva (AV.) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2024-07-26 15:49:15492.7051251.28O
2024-07-26 15:35:27492.701,3096,449.44O
2024-07-26 15:35:27492.701,039,1205,119,744.24UT
2024-07-26 15:31:10492.50524.63O
2024-07-26 15:30:57492.9026128.15O

Aviva (AV.) Top Chat Posts

Top Posts
Posted at 26/7/2024 09:20 by Aviva Daily Update
Aviva Plc is listed in the Insurance Carriers, Nec sector of the London Stock Exchange with ticker AV.. The last closing price for Aviva was 488.40p.
Aviva currently has 2,739,487,140 shares in issue. The market capitalisation of Aviva is £13,505,671,600.
Aviva has a price to earnings ratio (PE ratio) of 12.45.
This morning AV. shares opened at 487.30p
Posted at 05/7/2024 12:46 by hallucinogenix
I'm personally happy with high interest rates. Share prices performing ok...ish with dividend income for long term investors, and savings at 5-5.5% fixed for a few years very nice indeed.

Interest rates will probably come down in September and slowly decrease over the following year.

But totally understand we all have different views and investments which probably isn't good for those wanting to make a quick buck.
Posted at 01/7/2024 07:53 by lord gnome
A complete waste of capital on a pointless buy back that has made FA difference to the share price and removed a tiny fraction of the shares from the market. Why? Next time they have money to burn I'd prefer a special dividend.
Posted at 03/6/2024 08:14 by engelbert1969
I'm probably being naive, but it was the lack of any explanation from the insurer that I found most irritating.
Anyway always nice to wake up to a rising share price
Posted at 01/6/2024 15:15 by xtrmntr
From IC.Ten years ago, Aviva was a sprawling group of insurance businesses, a legacy from its days of expansion through bolt-on acquisitions. In 2015, then chief executive Mark Wilson set up an umbrella group to cross-sell between the group's life and general insurance product lines. His big idea was to harness technology to drive the business forward.The new team was set up not in an office block, but in an old garage in London's Hoxton Square, and so became known as the "technology garage". It developed "MyAviva", so that all of a customer's policies could be viewed in one place. Analysing the data enabled finer pricing to reward customers for the breadth and depth of their Aviva relationship, out of which AvivaPlus emerged – a promise never to charge Aviva customers more for their policies than new customers. Another part of the technology garage was an innovation team, set up to identify emerging trends and launch new concepts.This was a long-term strategy, the sort that investors support, but the short-term costs were high. Dramatic returns were promised, but after a while, shareholders began to have doubts. That's the problem with jam tomorrow – unless investors can see tangible value emerging, they begin to wonder whether tomorrow will ever come. This must have produced some frank discussions in the boardroom. In October 2018, Wilson left rather quickly.Sir Adrian Montague, who had been chairing the group as a non-executive, temporarily covered both roles. The search for a new chief executive was extensive, but they eventually chose from within. Maurice Tulloch had been with Aviva for over 25 years and was seen to be a safe pair of hands. A few months later, with the succession sorted out, Montague reached the end of his tenure and bowed out.In March 2019, Tulloch told shareholders that he aimed to increase return on investment. After so much emphasis on the technology garage, this was music to analysts' ears. Tulloch restored the dividing line between Aviva's general (home and motor) insurance and life insurance divisions. It went back to seeming like business as usual.Despite his back-to-basics approach, progress was sluggish. In his earlier role, Tulloch had been responsible for the speciality business, together with the life and general ones in France, Canada, Ireland, Italy, Poland, Turkey and India. Some were now calling for the group to be broken up. Instead, he restructured Aviva into five divisions with a promise of greater cash generation and an increased dividend. He also put the group's Singapore and China businesses up for sale, but this was just as the pandemic began to dampen confidence, and only low offers came in. The sale was pulled, but the lockdowns continued to squeeze cash out of the business. The 2019 final dividend had been announced but had to be withdrawn. The share price slumped from more than 400p pre-Covid to under 250p. Critics thought that he should have seen all this coming. They asked where the strategy was to reinvigorate the group.Meanwhile, the boardroom had a new clutch of directors. In the same year that Montague retired, four other non-executives left as well, so by the time George Culmer began chairing the group in late May 2020, many on the board were new. Having a new boss brings risks for any employee. Those who select candidates have a vested interest in seeing them succeed. They make allowances and tend to give them the benefit of the doubt. New bosses are often more critical and inclined to justify their new position by making changes. On 6 July 2020, just five weeks after Culmer took up the reins, Tulloch left "for family health reasons". He'd been chief executive for little over a year.One of the new non-executive directors was Amanda Blanc. She stepped seamlessly into the chief executive role. She would bring a renewed focus, she said, and that was how she'd increase returns.It took a while for her 'focus' to shine through. With lacklustre half-year financials in mid-2021, she promised better operational efficiency and pledged to return at least £4bn to shareholders over the next year through buybacks and dividends. She kept her word, and by the end of 2021, a total of eight businesses had been sold to raise £7.5bn, and other non-core operations followed. The slimmed-down Aviva has since added some small strategic acquisitions and the group is now concentrated in the UK, Ireland and Canada.The big unknown with recruitment is that, however much vetting is done, nobody can be certain about how well the successful candidate will take to the role until after they've started. With the low-hanging fruit plucked, only the future will tell whether Aviva is back on track, but there's no doubt that it's gone through some difficult but decisive succession planning – which is why it's important for non-executive directors to maintain independent and open states of mind.
Posted at 20/5/2024 21:29 by pj84
I posted the following as part of my post 18259 on 15 Dec 23

"The other major factor has been UK pension funds etc. moving form being major holders of UK shares to a now almost non-existent holding. But history tells us that things look darkest before the dawn and when the last seller has sold that is when the market turns, and UK pension funds no longer have any more shares to sell. So I am hopeful that the turnaround for most good quality high dividend paying companies has now started."

Nice to see the following from HSBC's investment bank in today's Telegraph belatedly agreeing.

"British stocks represent a golden buying opportunity, HSBC has said.

The investment bank has told clients to buy UK-listed stocks, arguing that downward pressure on share prices from pension funds selling almost £2 trillion of assets has ended.

“The long-term structural overhang of UK pension fund selling is at an end; they simply have no more UK equities left to sell,” the bank’s research team said."
Posted at 31/3/2024 15:04 by muscletrade
Have been away a few days and have caught up with the Exane downgrade and target share price of 420p.
This does come as a surprise and they are very much the outlier with lowest target price out there.

However Exane don't seem to pay that much attention to AV. They only started coverage in 2019 and have only issued 4 notes in all that time and have been consistent at either underweight or neutral..... it seems with little or no reference to the fact that AV is not the same company as it was was when they first started coverage in 2019.
Has anyone actually read the Exane note? would be interested to read if available.
Posted at 12/3/2024 15:06 by muscletrade
As of this morning based on a poll of 15 Analysts AV 12-Month Price Target
Average 499.07 (+5.51% Upside). The highest target price being 575p(source investing.com).
However at time of writing I have only seen two analyst notes from UBS and BOA since the results last week, who as we know both increased their share price target so it will be interesting to see what other analysts come up with.

I have also done a quick comparison between AV and L&G that some might find interesting.

L&G EPS 13.96p after stripping out longevity and internal pension schemes accounting(their figures and description) giving a PE of 18.36. which compares very favourably with AV.

Why should L&G be rated so much higher than AV????
Well they have a very solid record compared to AVs less than stellar performance (pre Blanc) and a much more consistent dividend record.

The other metric that L&G wins hands down is ROE. of 27.1% (excluding investment and other moves(their words again),AV is still only 12.7% albeit much better than 9.4% in 2022. So AV have much to do to get closer to ROE that L&G enjoy.

Much to play for. If they can continue to improve ROE the PE should follow. If perchance AV enjoyed the same PE as L&Gs 18.36 the share price would be (41x 18.36)...753p...(that isn't going to happen anytime soon unless they are bought out).

Apologies as if this all sounds like ramping. Of course I have interest in AV but Im not inventing imaginary figures , just doing the maths on the figures that are in the public domain.
Posted at 12/3/2024 10:21 by muscletrade
No one apart from UBS and BOA have come up with a valuation for the share price yet so I have done my own.

Trailing PE(for 2023) at today's share price of 469 and EPS of 37.7=12.44

This is a relatively modest PE for a company now in growth mode which the company have themselves confirmed by their 2023 results and also by increasing their capital generation from 1.467 to 2.0 billion

I have assumed that this translates into EPS of 41p for 2024(it could be slightly less or slightly more but is consistent with the improvement in 22/2023.

In the first instance I assume there is no improvement to the trailing PE for 2023
that provides (41 X 12.44)= share price of 510p

if there is a modest improvement to the PE to 13.0 (41 x 13.0) =SP of 533p

if there is a larger improvement to the PE to 13.5 (41 x 13.5) =SP of 554p

My understanding is that the PE of the higher valued insurance companies is closer to 18 than 13.5 so it doesn't seem to me unreasonable that the market might begin to recognise the progress underway and price in a higher PE. (one hopes, but it seems entirely logical).

Conclusion....even allowing for no improvement in PE the share price should be around 510p based upon what AV have already forecast.

If the market recognise that there should be a higher valuation based on growth forecasts then a share price of 554p is hardly expensive when compared to peer group with higher PEs.

One of the metrics that has held Av back is the pretty dismal ROE.
which was only 9.9% in 2022. this increased 48% to a more respectable 14.7% in 2023 and should increase again in 2024....which in turn should also support a higher PE valuation.

Please feel free to offer comments(please be kind, in fact I would welcome them
Posted at 11/3/2024 08:08 by andyble
Yes Aviva is slimmed down nicely enough for a sale but now they have done that they will be getting told that if the share price does not rise then they will be taken over. This may explain why they are so bullish presently talking up prospects, but for us the share price rises either way. I actually thought Aviva would be sold by the end of last year, but am holding my breath still, and fun to watch the future unfold from here else the continuing business success to £2B operating profit in due course.
Posted at 08/3/2024 07:30 by cjac39
1rob what would you say the adjusted price is today vs pre all the disposals? Presumably adjust for the special of 3.75? I think 100 shares became 76 so 4.6 today share price is worth 6.1 in old share price money?
Aviva share price data is direct from the London Stock Exchange

Your Recent History

Delayed Upgrade Clock